Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05225103 · ClinicalTrials.gov registry record · NA

Brief Suicide Intervention for Youth in Juvenile Detention Settings

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
8
Enrollment target

NCT05225103: Completed NA study, sponsored by Duke University.

NCT05225103 is a NA study that has completed, run by Duke University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05225103, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

This is an intervention development study and therefore is not designed or powered to test hypotheses. Following initial development and refinement of intervention and protocol, an open trial will be conducted at one juvenile detention facility (n=20). Following further refinement, six juvenile detention sites will be randomized to first or second wave of intervention implementation. All youth at an implementation site in suicidal crises will receive the intervention. Data will only be collected from youth with prior assent/consent. Youth will be assessed at the time of the suicidal/self-harm crisis, and at 2 and 4 weeks after initial intervention, and at a two-month follow-up assessment. We will preliminarily examine feasibility of the intervention and associated patterns of suicidal thoughts and behavior and non-suicidal self-injury, linkage to care following release, and presumed mechanisms of change such as hopelessness, self-efficacy to remain safe, urgency to act on suicidal thoughts, and acceptance.

Primary Outcome

Determined by a response of "yes" to question #6 on the C-SSRS: "Have you done anything, started to do anything, or prepared to do anything to end your life?"

Interventions

  • BEHAVIORAL SAFETY-Acute intervention

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2023-04-07
Est. Completion 2024-02-29
Phase NA
Duke University

1,725 total trials

What the finished NCT05225103 record still lists

NCT05225103 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which SAFETY-Acute intervention is the first listed.

NCT05225103 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05225103 about?

NCT05225103 is a clinical study titled "Brief Suicide Intervention for Youth in Juvenile Detention Settings". This is an intervention development study and therefore is not designed or powered to test hypotheses. Following initial development and refinement of intervention and protocol, an open trial will be conducted at one juvenile detention facility (n=20). Following further refinement, six juvenile dete...

What is the current status of trial NCT05225103?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2023-04-07. Estimated completion is 2024-02-29.

What interventions are being tested in trial NCT05225103?

The interventions under investigation include: SAFETY-Acute intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05225103?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05225103's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05225103, the US trial registry maintained by the National Library of Medicine. NCT05225103 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.